Serum prostate-specific antigen (PSA) level has been widely used to detect prostate cancer and monitor its treatment, including surgical therapy, radiotherapy, hormonal therapy, chemotherapy, and active surveillance. The gene discussed is KLK3; the disease is prostate carcinoma.